Redmile Group as of March 31, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 76 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 8.8 | $204M | 18M | 11.09 | |
Krystal Biotech (KRYS) | 6.6 | $153M | 1.9M | 80.06 | |
Iveric Bio | 4.4 | $102M | 4.2M | 24.33 | |
Deciphera Pharmaceuticals (DCPH) | 3.7 | $86M | 5.6M | 15.45 | |
Akero Therapeutics (AKRO) | 3.4 | $78M | 2.0M | 38.26 | |
Pliant Therapeutics (PLRX) | 3.4 | $78M | 2.9M | 26.60 | |
Fate Therapeutics (FATE) | 3.2 | $74M | 13M | 5.70 | |
Kymera Therapeutics (KYMR) | 3.1 | $71M | 2.4M | 29.63 | |
Celldex Therapeutics Com New (CLDX) | 2.9 | $68M | 1.9M | 35.98 | |
Replimune Group (REPL) | 2.9 | $67M | 3.8M | 17.66 | |
Zymeworks Del (ZYME) | 2.4 | $55M | 6.1M | 9.04 | |
Penumbra (PEN) | 2.3 | $52M | 188k | 278.69 | |
Livanova SHS (LIVN) | 2.2 | $52M | 1.2M | 43.58 | |
Beam Therapeutics (BEAM) | 2.1 | $49M | 1.6M | 30.62 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $49M | 335k | 146.33 | |
Argenx Se Sponsored Adr (ARGX) | 2.1 | $49M | 131k | 372.58 | |
Xenon Pharmaceuticals (XENE) | 2.1 | $48M | 1.3M | 35.79 | |
Igm Biosciences (IGMS) | 2.0 | $46M | 3.3M | 13.74 | |
Oak Street Health | 1.8 | $41M | 1.1M | 38.68 | |
Catalent (CTLT) | 1.7 | $40M | 610k | 65.71 | |
Dex (DXCM) | 1.7 | $39M | 336k | 116.18 | |
Stryker Corporation (SYK) | 1.7 | $39M | 137k | 285.47 | |
Stoke Therapeutics (STOK) | 1.5 | $35M | 4.1M | 8.33 | |
BioMarin Pharmaceutical (BMRN) | 1.4 | $33M | 335k | 97.24 | |
Sarepta Therapeutics (SRPT) | 1.4 | $32M | 232k | 137.83 | |
Bristol Myers Squibb (BMY) | 1.4 | $31M | 449k | 69.31 | |
Regenxbio Inc equity us cm (RGNX) | 1.3 | $31M | 1.6M | 18.91 | |
ImmunoGen | 1.3 | $31M | 8.0M | 3.84 | |
Anthem (ELV) | 1.3 | $31M | 66k | 459.81 | |
Ventyx Biosciences (VTYX) | 1.2 | $27M | 816k | 33.50 | |
Entrada Therapeutics (TRDA) | 1.2 | $27M | 1.8M | 14.50 | |
Adc Therapeutics Sa SHS (ADCT) | 1.1 | $27M | 14M | 1.95 | |
Humana (HUM) | 1.1 | $25M | 52k | 485.46 | |
Augmedix (AUGX) | 1.1 | $25M | 14M | 1.74 | |
Scholar Rock Hldg Corp (SRRK) | 1.1 | $25M | 3.1M | 8.00 | |
Repare Therapeutics Ord (RPTX) | 1.1 | $25M | 2.5M | 9.84 | |
Prime Medicine (PRME) | 1.1 | $25M | 2.0M | 12.30 | |
Nurix Therapeutics (NRIX) | 1.1 | $24M | 2.7M | 8.88 | |
Stevanato Group S P A Ord Shs (STVN) | 1.0 | $23M | 902k | 25.90 | |
Charles River Laboratories (CRL) | 1.0 | $23M | 115k | 201.82 | |
Immunovant (IMVT) | 0.9 | $20M | 1.3M | 15.51 | |
Gritstone Oncology Ord (GRTS) | 0.8 | $19M | 6.9M | 2.78 | |
Centene Corporation (CNC) | 0.8 | $18M | 277k | 63.21 | |
Shattuck Labs (STTK) | 0.7 | $17M | 5.6M | 2.94 | |
Atara Biotherapeutics (ATRA) | 0.7 | $16M | 5.6M | 2.90 | |
Verve Therapeutics (VERV) | 0.7 | $16M | 1.1M | 14.42 | |
Iqvia Holdings (IQV) | 0.6 | $14M | 72k | 198.89 | |
Absci Corp (ABSI) | 0.6 | $14M | 8.0M | 1.75 | |
89bio (ETNB) | 0.6 | $14M | 900k | 15.23 | |
Annexon (ANNX) | 0.6 | $14M | 3.5M | 3.85 | |
Rapt Therapeutics (RAPT) | 0.5 | $13M | 688k | 18.35 | |
Allakos (ALLK) | 0.4 | $10M | 2.3M | 4.45 | |
Medavail Holdings Ord | 0.4 | $9.9M | 35M | 0.29 | |
Boston Scientific Corporation (BSX) | 0.4 | $8.6M | 172k | 50.03 | |
Illumina (ILMN) | 0.3 | $7.8M | 34k | 232.55 | |
Allovir (ALVR) | 0.3 | $7.5M | 1.9M | 3.94 | |
Science 37 Holdings | 0.2 | $5.6M | 20M | 0.28 | |
Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.2 | $5.3M | 721k | 7.37 | |
Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.0M | 3.0M | 1.66 | |
Somalogic Class A Com | 0.2 | $4.8M | 1.9M | 2.55 | |
Lava Therapeutics Nv SHS (LVTX) | 0.1 | $3.4M | 2.1M | 1.66 | |
Invitae (NVTAQ) | 0.1 | $3.1M | 2.3M | 1.35 | |
Stereotaxis Com New (STXS) | 0.1 | $3.0M | 1.5M | 2.04 | |
Alx Oncology Hldgs (ALXO) | 0.1 | $2.7M | 587k | 4.52 | |
Cabaletta Bio (CABA) | 0.1 | $2.3M | 274k | 8.27 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $1.9M | 2.6M | 0.74 | |
Adagio Therapeutics (IVVD) | 0.1 | $1.7M | 1.4M | 1.20 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $1.7M | 1.0M | 1.63 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.5M | 1.6M | 0.96 | |
Neoleukin Therapeutics | 0.1 | $1.3M | 1.8M | 0.70 | |
Alpha Teknova (TKNO) | 0.0 | $1.1M | 373k | 2.96 | |
Sonendo (SONX) | 0.0 | $996k | 498k | 2.00 | |
Tcr2 Therapeutics Inc cs | 0.0 | $988k | 658k | 1.50 | |
Cytosorbents Corp Com New (CTSO) | 0.0 | $612k | 182k | 3.37 | |
Atreca Cl A Com (BCEL) | 0.0 | $505k | 443k | 1.14 | |
Oncology Institu (TOI) | 0.0 | $216k | 318k | 0.68 |